6584 Organometallics, Vol. 26, No. 26, 2007
Han et al.
(m, 3J(H,H) ) 7.2 Hz, 2 H, CH2), 4.03 (s, 3 H, NCH3), 2.49 (s, 3
H, CH3), 2.45 (s, 3 H, CH3), 1.30 (t, 3J(H,H) ) 7.2 Hz, 3 H,
CH2CH3). 13C{1H} NMR (75.47 MHz, DMSO-d6): δ 147.9, 146.8
(s, CCH3), 69.3 (s, CI), 43.2 (s, CH2), 35.1 (s, NCH3), 13.7, 13.2,
12.8 (s, CH3). Anal. Calcd for C8H14I2N2: C, 24.51; H, 3.60; N,
7.15. Found: C, 24.76; H, 3.80; N, 7.06. MS (ESI): m/z 265
[M - I]+.
catalyzed aqueous Suzuki-Miyaura coupling showed that the
novel cationic complexes give rise to more active catalysts than
their corresponding neutral counterparts. Research in our
laboratories is underway to extend the synthetic methodology
to other transition metals as well as to widen the scope of rNHC
complexes in catalysis.
cis-(2-Ethyl-3,5-dimethyl-1-phenylpyrazolin-4-ylidene)diiodo
(triphenylphosphine)palladium(II)(4a).Tris(dibenzylideneacetone)
dipalladium(0) (229 mg, 0.25 mmol) and triphenylphosphine (131
mg, 0.50 mmol) were dissolved in dry CH2Cl2 (30 mL) and stirred
at ambient temperature for 10 min under nitrogen. The resulting
dark-red solution was transferred to a suspension of 3a (227 mg,
0.5 mmol) in dry CH2Cl2 (20 mL) via cannula. The reaction mixture
was heated under reflux for 4 h in an inert nitrogen atmosphere
and then cooled to ambient temperature. The resulting mixture was
filtered through Celite, and the filtrate was extracted with H2O (4
× 30 mL). The CH2Cl2 layer was dried over MgSO4, and the solvent
was removed under reduced pressure. The residue was washed with
diethyl ether (2 × 30 mL) and dried in vacuo to give the crude
product as a yellow powder. Slow evaporation of a concentrated
CH2Cl2 solution at ambient temperature afforded the pure product
as yellow crystals (290 mg, 0.35 mmol, 70%). 1H NMR (300 MHz,
CD2Cl2): δ 7.78–6.87 (m, 20 H, Ar-H), 3.78 (m, 2J(H,H) ) 15.4
Experimental Section
General Considerations. Unless otherwise noted, all operations
were performed without taking precautions to exclude air and
moisture. All solvents and chemicals were used as received without
any further treatment if not noted otherwise. 1,3,5-Trimethylpyra-
zole was purchased from Sigma-Aldrich. Tris(dibenzylideneac-
etone)dipalladium(0) was received from Alfa Aesar. 1H, 13C, 31P,
and 19F NMR spectra were recorded on Bruker ACF 300 and AMX
500 spectrometers, and the chemical shifts (δ) were internally
referenced to the residual solvent signals relative to tetramethylsilane
(1H and 13C NMR) or externally to 85% H3PO4 (31P NMR) and
CF3CO2H (19F NMR). Mass spectra were measured using a
Finnigan MAT LCQ (ESI) spectrometer. Elemental analyses were
performed on a Perkin-Elmer PE 2400 elemental analyzer at the
Department of Chemistry, National University of Singapore.
4-Iodo-3,5-dimethyl-1-phenylpyrazole (2a). An aqueous solu-
tion of KI3 [prepared by dissolving I2 (1505 mg, 5.95 mmol) and
KI (2955 mg, 17.8 mmol) in H2O (20 mL)] was added dropwise to
a solution of 3,5-dimethyl-1-phenylpyrazole (520 mg, 3 mmol) and
NaOAc (535 mg, 5.65 mmol) in H2O (12 mL) under reflux. The
resulting dark-brown solution was kept under reflux for another
7 h and then cooled to ambient temperature. Subsequently, an
aqueous solution of Na2S2O3 was added dropwise until the reaction
mixture was decolored. The product was extracted with diethyl ether
(4 × 30 mL). The combined organic layer was washed with
NaHCO3 (2 × 40 mL) and brine (2 × 40 mL). Drying over MgSO4
followed by removal of the solvent in vacuo afforded the product
3
2
Hz, J(H,H) ) 7.2 Hz, 1 H, CH2), 3.63 (m, J(H,H) ) 15.4 Hz,
3J(H,H) ) 7.2 Hz, 1 H, CH2), 2.36 (s, 3 H, CH3), 1.99 (s, 3 H,
3
CH3), 0.95 (m, J(H,H) ) 7.2 Hz, 3 H, CH2CH3). 31P{1H} NMR
(121 MHz, CD2Cl2): δ 29.4 (s, 1 P, PPh3). 13C{1H} NMR (75.47
3
MHz, CD2Cl2): δ 147.2 (d, J(P,C) ) 3.8 Hz, CCH3), 146.9 (d,
3J(P,C) ) 2.7 Hz, CCH3), 134.9 (d, 2/3J(P,C) ) 11.0 Hz, Ar-C),
132.9 (d, 1J(P,C) ) 48.3 Hz, Ar-C), 132.3, 131.6, 130.5 (s, Ar-C),
130.2 (d, 4J(P,C) ) 2.2 Hz, Ar-C), 130.1, 128.7, 127.8 (s, Ar-C),
127.7 (d, 2/3J(P,C) ) 11.0 Hz, Ar-C), 41.9 (s, CH2), 15.3, 15.1,
14.7(s, CH3), carbene signal not detected. Anal. Calcd for
C31H31I2N2PPd: C, 45.25; H, 3.80; N, 3.40. Found: C, 45.03; H,
4.28; N, 3.18. MS (ESI): m/z 695 [M - I]+.
1
as a brown oil (827 mg, 2.8 mmol, 93%). H NMR (300 MHz,
CDCl3): δ 7.48–7.33 (m, 5 H, Ar-H), 2.32 (s, 3 H, CH3), 2.30 (s,
3 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): δ 150.8 (s, CCH3),
140.9, 140.0 (s, CCH3/Ar-C), 129.2, 128.0, 124.9 (s, Ar-C), 65.4
(s, CI), 14.2, 13.5 (s, CH3). Anal. Calcd for C11H11IN2: C, 44.32;
H, 3.72; N, 9.40. Found: C, 44.78; H, 3.78; N, 9.45. MS (ESI):
m/z 299 [M + H]+.
4-Iodo-1,3,5-trimethylpyrazole (2b). 2b was prepared analo-
gously to 2a from 1,3,5-trimethylpyrazole (441 mg, 4 mmol). The
product was purified by chromatography on silica using diethyl
ether. Yield: 637 mg, 2.7 mmol, 67%. 1H NMR (300 MHz, CDCl3):
δ 3.77 (s, 3 H, NCH3), 2.24 (s, 3 H, CH3), 2.19 (s, 3 H, CH3).
13C{1H} NMR (75.47 MHz, CDCl3): δ 149.0 (s, CCH3), 140.7 (s,
CCH3), 62.2 (s, CI), 37.1 (s, NCH3), 14.0, 12.0 (s, CH3). Anal.
Calcd for C6H9IN2: C, 30.53; H, 3.84; N, 11.87. Found: C, 30.89;
H, 3.76; N, 11.60. MS (ESI): m/z 237 [M + H]+.
cis-(1-Ethyl-2,3,5-trimethylpyrazolin-4-ylidene)diiodo(triph-
enylphosphine)palladium(II) (4b). 4b was prepared analogously
to 4a from 3b (196 mg, 0.5 mmol), tris(dibenzylideneacetone)di-
palladium(0) (229 mg, 0.25 mmol), and triphenylphosphine (131
1
mg, 0.50 mmol). Yield: 228 mg, 0.30 mmol, 60%. H NMR (500
3
MHz, CD2Cl2): δ 7.67–7.31 (m, 15 H, Ar-H), 3.86 (m, J(H,H)
) 7.3 Hz, 2 H, CH2), 3.43 (s, 3 H, NCH3), 2.21 (s, 3 H, CH3),
3
2.13 (s, 3 H, CH3), 1.15 (m, J(H,H) ) 7.3 Hz, 3 H, CH2CH3).
31P{1H} NMR (202 MHz, CD2Cl2): δ 29.3 (s, 1 P, PPh3). 13C{1H}
NMR (125.76 MHz, CD2Cl2): δ 145.9 (d, 3J(P,C) ) 4.6 Hz, CCH3),
145.4 (d, 3J(P,C) ) 3.7 Hz, CCH3), 135.0 (d, 2/3J(P,C) ) 11.0 Hz,
Ar-C), 132.7 (d, 1J(P,C) ) 48.6 Hz, Ar-C), 130.2 (d, 4J(P,C) )
1.8 Hz, Ar-C), 127.7 (d, 2/3J(P,C) ) 11.0 Hz, Ar-C), 41.6 (s,
CH2), 33.2 (s, NCH3), 15.0, (s, CH3), 14.9 (s, CH3), 14.7 (s, CH3),
carbene signal not detected. Anal. Calcd for C26H29I2N2PPd ·
CH2Cl2: C, 38.35; H, 3.69; N, 3.31. Found: C, 38.47; H, 3.85; N,
3.22. MS (ESI): m/z 633 [M - I]+.
2-Ethyl-4-iodo-3,5-dimethyl-1-phenylpyrazolium Iodide (3a). 2a
(713 mg, 2.4 mmol) was dissolved in iodoethane (2 mL) and heated
under reflux for 2 days shielded from light. The reaction mixture
was cooled to ambient temperature, and all volatiles were removed
under reduced pressure. The residue was washed with diethyl ether
and dried in vacuo to give the product as an off-white powder (545
2-Ethyl-4-iodo-3,5-dimethyl-1-phenylpyrazolium Triflate (5a).
3a (197 mg, 0.43 mmol) and silver triflate (118 mg, 0.46 mmol)
were suspended in CH3CN (5 mL) and stirred at ambient temper-
ature for 30 min shielded from light. The reaction mixture was
filtered through Celite, and the solvent of the filtrate was evaporated
off. To the residue was added CH2Cl2 (15 mL), and the resulting
mixture was filtered through Celite. Removal of the solvent in vacuo
afforded the product as an off-white powder (201 mg, 0.42 mmol,
98%). 1H NMR (300 MHz, CDCl3): δ 7.74–7.62 (m, 5 H, Ar-H),
4.29 (m, 3J(H,H) ) 7.3 Hz, 2 H, CH2), 2.62 (s, 3 H, CH3), 2.24 (s,
1
mg, 1.2 mmol, 50%). H NMR (300 MHz, CDCl3): δ 7.81–7.65
3
(m, 5 H, Ar-H), 4.39 (m, J(H,H) ) 7.3 Hz, 2 H, CH2), 2.70 (s,
3
3 H, CH3), 2.25 (s, 3 H, CH3), 1.22 (t, J(H,H) ) 7.3 Hz, 3 H,
CH2CH3). 13C{1H} NMR (75.47 MHz, CDCl3): δ 149.9, 149.8 (s,
CCH3), 133.6, 131.8, 131.6, 129.8 (s, Ar-C), 72.6 (s, CI), 46.7 (s,
CH2), 15.4 (s, C CH3), 15.0 (s, CH2CH3). Anal. Calcd for
C13H16I2N2: C, 34.39; H, 3.55; N, 6.17. Found: C, 34.78; H, 3.45;
N, 6.19. MS (ESI): m/z 327 [M - I]+.
3
3 H, CH3), 1.20 (t, J(H,H) ) 7.3 Hz, 3 H, CH2CH3). 19F{1H}
1-Ethyl-4-iodo-2,3,5-trimethylpyrazolium Iodide (3b). 3b was
prepared analogously to 3a from 2b (283 mg, 1.2 mmol). Yield:
153 mg, 0.39 mmol, 33%. 1H NMR (300 MHz, DMSO-d6): δ 4.54
NMR (282 MHz, CDCl3): δ -2.3 (s, 3 F, CF3). 13C{1H} NMR
(75.47 MHz, CDCl3): δ 149.6, 149.5 (s, CCH3), 133.2, 131.5, 131.2,
129.0 (s, Ar-C), 120.8 (m, 1J(C,F) ) 320.7 Hz, CF3), 67.8 (s,